Ginkgo Bioworks (DNA) Tops Q2 EPS by 13c
Tweet
Share
E-mail
Get Alerts DNA Hot Sheet
Join SI Premium – FREE
Ginkgo Bioworks (NYSE: DNA) reported Q2 EPS of ($0.92), $0.13 better than the analyst estimate of ($1.05). Revenue for the quarter came in at $20 million versus the consensus estimate of $29.9 million.
For earnings history and earnings-related data on Ginkgo Bioworks (DNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cencora says Walgreens volumes shift, reaffirms guidance, shares sink
- Dyadic International, Inc. (DYAI) Misses Q2 EPS by 2c
- Okta upgraded as AI security opportunity boosts outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
